Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issues
This issue
20-3
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
20-3
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #27170
advertisement
Liu K
25
Showing records 1 to 25 |
Display all abstracts from
Liu K
80614
Comparison between pars plana and anterior endoscopic cyclophotocoagulation for the treatment of glaucoma
Feinstein MA
Clinical and Experimental Ophthalmology
2019; 47: 766-773
81446
Efficacy and safety of prostaglandin analogues in primary open-angle glaucoma or ocular hypertension patients: A meta-analysis
Tang W
Medicine
2019; 98: e16597
80575
Phase 2, Randomized, Dose-finding Studies of Omidenepag Isopropyl, a Selective EP2 Agonist, in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Aihara M
Journal of Glaucoma
2019; 28: 375-385
81361
Rosiglitazone Treatment Prevents Postoperative Fibrosis in a Rabbit Model of Glaucoma Filtration Surgery
Zhang F; Liu K
Investigative Ophthalmology and Visual Science
2019; 60: 2743-2752
80575
Phase 2, Randomized, Dose-finding Studies of Omidenepag Isopropyl, a Selective EP2 Agonist, in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Lu F
Journal of Glaucoma
2019; 28: 375-385
80614
Comparison between pars plana and anterior endoscopic cyclophotocoagulation for the treatment of glaucoma
Lee JH
Clinical and Experimental Ophthalmology
2019; 47: 766-773
81446
Efficacy and safety of prostaglandin analogues in primary open-angle glaucoma or ocular hypertension patients: A meta-analysis
Zhang F
Medicine
2019; 98: e16597
80575
Phase 2, Randomized, Dose-finding Studies of Omidenepag Isopropyl, a Selective EP2 Agonist, in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Kawata H
Journal of Glaucoma
2019; 28: 375-385
81446
Efficacy and safety of prostaglandin analogues in primary open-angle glaucoma or ocular hypertension patients: A meta-analysis
Liu K
Medicine
2019; 98: e16597
80614
Comparison between pars plana and anterior endoscopic cyclophotocoagulation for the treatment of glaucoma
Amoozgar B
Clinical and Experimental Ophthalmology
2019; 47: 766-773
81361
Rosiglitazone Treatment Prevents Postoperative Fibrosis in a Rabbit Model of Glaucoma Filtration Surgery
Cao M
Investigative Ophthalmology and Visual Science
2019; 60: 2743-2752
81446
Efficacy and safety of prostaglandin analogues in primary open-angle glaucoma or ocular hypertension patients: A meta-analysis
Duan X
Medicine
2019; 98: e16597
80575
Phase 2, Randomized, Dose-finding Studies of Omidenepag Isopropyl, a Selective EP2 Agonist, in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Iwata A
Journal of Glaucoma
2019; 28: 375-385
80614
Comparison between pars plana and anterior endoscopic cyclophotocoagulation for the treatment of glaucoma
Liu K
Clinical and Experimental Ophthalmology
2019; 47: 766-773
81361
Rosiglitazone Treatment Prevents Postoperative Fibrosis in a Rabbit Model of Glaucoma Filtration Surgery
Qu J; Zhou D
Investigative Ophthalmology and Visual Science
2019; 60: 2743-2752
80575
Phase 2, Randomized, Dose-finding Studies of Omidenepag Isopropyl, a Selective EP2 Agonist, in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Liu K
Journal of Glaucoma
2019; 28: 375-385
80614
Comparison between pars plana and anterior endoscopic cyclophotocoagulation for the treatment of glaucoma
Stewart JM
Clinical and Experimental Ophthalmology
2019; 47: 766-773
81361
Rosiglitazone Treatment Prevents Postoperative Fibrosis in a Rabbit Model of Glaucoma Filtration Surgery
Pan Z
Investigative Ophthalmology and Visual Science
2019; 60: 2743-2752
80575
Phase 2, Randomized, Dose-finding Studies of Omidenepag Isopropyl, a Selective EP2 Agonist, in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Odani-Kawabata N
Journal of Glaucoma
2019; 28: 375-385
80614
Comparison between pars plana and anterior endoscopic cyclophotocoagulation for the treatment of glaucoma
Lazcano-Gomez G
Clinical and Experimental Ophthalmology
2019; 47: 766-773
81361
Rosiglitazone Treatment Prevents Postoperative Fibrosis in a Rabbit Model of Glaucoma Filtration Surgery
Duan X
Investigative Ophthalmology and Visual Science
2019; 60: 2743-2752
80614
Comparison between pars plana and anterior endoscopic cyclophotocoagulation for the treatment of glaucoma
Porco T
Clinical and Experimental Ophthalmology
2019; 47: 766-773
80575
Phase 2, Randomized, Dose-finding Studies of Omidenepag Isopropyl, a Selective EP2 Agonist, in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Shams NK
Journal of Glaucoma
2019; 28: 375-385
81361
Rosiglitazone Treatment Prevents Postoperative Fibrosis in a Rabbit Model of Glaucoma Filtration Surgery
Zhou Y
Investigative Ophthalmology and Visual Science
2019; 60: 2743-2752
80614
Comparison between pars plana and anterior endoscopic cyclophotocoagulation for the treatment of glaucoma
Han Y
Clinical and Experimental Ophthalmology
2019; 47: 766-773
Issue
20-3
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept